The FDA’s Center for Devices & Radiological Health aims to improve its clinical trial process, better balance pre- and post-market data gathering and “provide excellent customer service” in 2014.
DA Mulls Faster OK for High-Ned Devices; The FDA wants to create an expedited approval pathway for high-risk medical devices for unmet needs, saying current tools at its fingertips are ineffective for speedier approvals.
The FDA’s powers to reclassify devices were restricted by a federal appeals court ruling that said the agency does not have the inherent authority to reclassify devices. Rather, the FDA must follow Congress’s procedural requirements when reclassifying devices, including notice and comment procedures.
Nightscout touts itself as an open-source, do-it-yourself project to enable remote monitoring of blood glucose levels in patients with Type 1 diabetes.
The iGrow Hair Growth System, a device the company claims to promote male hair growth, won FDA clearance in September 2014 for over-the-counter sales.
In First, FDA Sends Warning Letters to Companies Citing Use of Pinterest: The US Food and Drug Administration’s (FDA) long history of Warning Letters marked a new milestone today after regulators chided three companies, including one which marketed its product on a medium never before cited by FDA: Pinterest.
Primary care doctors may be able to run a blood panel to diagnose depression. Researchers at Northwestern University’s Feinberg School of Medicine have identified 9 RNA blood markers that can be used as part of a panel to diagnose the mental disorder. They said it is the first blood test to diagnose adult depression. They published the results of their study in the Sept. 16 issue of the Nature journalTranslational Psychiatry.
Amid mounting industry pressure to unveil a therapy to counter the deadly Ebola outbreak, researchers are developing an innovative dialysis device that fights the disease by filtering blood.
Dow Jones writer Brian Gormley set out to find out the answer to that question, reviewing the venture data for biotech and med tech in Dow Jones’ VentureSource database. He concluded that eye diseases warranted the biggest single wager on any particular organ, with a total of $849 million in venture bets on ophthalmology startups in the field. And $442.7 million more came in the first half of this year, indicating that there’s been no letup in the action.
Hospitals affiliated with Stanford and Duke University are initiating partnerships with Apple and its yet to be unveiled HealthKit, designed to collect data from healthcare apps and present it to doctors in a centralized location.